Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Miragen Therapeutics Inc (NQ: MGEN )

23.03 USD -1.90 (-7.62%)
Official Closing Price Updated: 7:58 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Miragen Therapeutics Inc

< Previous 1 2 3 Next >
miRagen Enters into License Agreement with Xencor for use of Xtend™ Antibody Technology for Investigational Antibodies to Treat Thyroid Eye Disease
From GlobeNewswire News Releases
miRagen Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
From GlobeNewswire News Releases
Thinking about buying stock in Miragen Therapeutics, Trevena, Norwegian Cruise Line, American Resources, or Delta Air Lines?
InvestorsObserver issues critical PriceWatch Alerts for MGEN, TRVN, NCLH, AREC, and DAL. 
From PR Newswire
Thinking about buying stock in Miragen Therapeutics, Nio, Scholar Rock, General Electric, or Boeing?
InvestorsObserver issues critical PriceWatch Alerts for MGEN, NIO, SRRK, GE, and BA. 
From PR Newswire
miRagen Therapeutics, Inc. Announces Acquisition of Viridian Therapeutics, Inc.
From GlobeNewswire News Releases
miRagen Announces Internal Review of Preliminary Topline Data for the Phase 2 SOLAR Clinical Trial of Cobomarsen in Patients with Cutaneous T-Cell Lymphoma (CTCL)
miRagen decides to discontinue further internal development of cobomarsen 
From GlobeNewswire News Releases
miRagen Announces Leadership Transition and Review of Strategic Alternatives
From GlobeNewswire News Releases
miRagen Announces Results of Meeting With FDA Regarding the Design of Pivotal Trial for Cobomarsen in ATLL
From GlobeNewswire News Releases
miRagen Reports Second Quarter 2020 Financial Results and Provides Business Updates
From GlobeNewswire News Releases
miRagen to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
From GlobeNewswire News Releases
Stochastic K% D% Indicates Bullish US Stocks: $CIDM $STM $MGEN
Tags The Market Signal
From The Market Signal
miRagen, Investigators from Goethe University and University Hospital Frankfurt and Servier Publish MRG-110 Phase 1 Pharmacodynamic Biomarker Data in Nucleic Acid Therapeutics
From GlobeNewswire News Releases
Thinking about buying stock in Miragen Therapeutics, ChannelAdvisor, Northern Dynasty Minerals, Tiziana Life Sciences, or Tonix Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for MGEN, ECOM, NAK, TLSA, and TNXP. 
From PR Newswire
Cobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell Lymphoma
From GlobeNewswire News Releases
miRagen to Report Second Quarter 2020 Financial Results on August 5, 2020
From GlobeNewswire News Releases
Thinking about buying stock in New Age Beverages, Lexicon Pharmaceuticals, Miragen Therapeutics, Opko Health, or Niu Technologies?
InvestorsObserver issues critical PriceWatch Alerts for NBEV, LXRX, MGEN, OPK, and NIU. 
From PR Newswire
miRagen Regains Compliance With Nasdaq Listing Requirements
From GlobeNewswire News Releases
miRagen Announces Encouraging Preclinical Safety and Efficacy Data for its Next-generation miR-29 Replacement Product Candidate Intended for the Treatment of Idiopathic Pulmonary Fibrosis
Key Opinion Leader call on IPF scheduled for 11 a.m. ET on Tuesday, June 23rd 
From GlobeNewswire News Releases
Thinking about buying stock in Virgin Galactic, Miragen Therapeutics, Nantkwest Inc, Agenus Inc, or Norwegian Cruise Line?
InvestorsObserver issues critical PriceWatch Alerts for SPCE, MGEN, NK, AGEN, and NCLH. 
From PR Newswire
miRagen Strengthens Leadership Team with Appointment of Lee Rauch as Chief Operating Officer
From GlobeNewswire News Releases
Thinking about buying stock in Energous Corp, Miragen Therapeutics, Hertz, Kopin Corp, or MGM Resorts?
InvestorsObserver issues critical PriceWatch Alerts for WATT, MGEN, HTZ, KOPN, and MGM. 
From PR Newswire
miRagen to Host a Key Opinion Leader Call on Idiopathic Pulmonary Fibrosis on Tuesday, June 23rd
miRagen to announce encouraging new preclinical safety and efficacy data for MRG-229 in IPF on June 22nd; and provide an update on the development program during the KOL call 
From GlobeNewswire News Releases
miRagen to Present at the Jefferies 2020 Virtual Global Healthcare Conference
From GlobeNewswire News Releases
miRagen Reports First Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
miRagen Therapeutics to Report First Quarter 2020 Financial Results On May 7, 2020
From GlobeNewswire News Releases
miRagen Reports Fourth Quarter and Full Year 2019 Financial Results
From GlobeNewswire News Releases
miRagen Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on March 11, 2020
From GlobeNewswire News Releases
miRagen Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants to Purchase Common Stock
From GlobeNewswire News Releases
miRagen Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
From GlobeNewswire News Releases
Thinking about buying stock in Beyond Meat, Miragen Therapeutics, Microsoft, Nio, or Sunrun?
InvestorsObserver issues critical PriceWatch Alerts for BYND, MGEN, MSFT, NIO, and RUN. 
From PR Newswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.